美托洛尔联合稳心颗粒治疗高血压心脏病室性早搏的效果观察

Effect observation of metoprolol combined with Wen Xin granule in the treatment of hypertensive heart disease ventricular premature beat

目的:探究美托洛尔联合稳心颗粒治疗高血压心脏病室性早搏的临床疗效。方法:2012年5月-2014年5月收治高血压心脏病室性早搏患者56例,随机分为试验组和对照组,试验组给予美托洛尔联合稳心颗粒治疗,对照组给予美托洛尔单独治疗,观察两组患者临床疗效及不良反应发生率。结果:试验组临床疗效明显高于对照组,差异有统计学意义(P<0.05);两组患者不良反应发生率相比差异较小,无统计学意义(P>0.05)。结论:美托洛尔联合稳心颗粒治疗高血压心脏病室性早搏具有显著的临床疗效,不良反应较少,值得在临床上推广使用。

Objective:To explore the clinical effect of metoprolol combined with Wen Xin granule in the treatment of hypertensive heart disease ventricular premature beat.Methods:56 patients with hypertensive heart disease ventricular premature beat were selected from May 2012 to May 2014.They were randomly divided into the experimental group and the control group.The experimental group were given metoprolol combined with Wen Xin granule treatment.The control group were given metoprolol treatment alone.The clinical curative effect and the incidence rate of adverse reaction of two groups were observed.Results:The clinical curative effect of the patients in the experimental group were significantly higher than those of the control group,and the difference was statistically significant(P<0.05).The incidence rate of adverse reaction of two groups compared to smaller differences with no statistical significance(P>0.05).Conclusion:Metoprolol combined with Wen Xin granule in the treatment of hypertensive heart disease ventricular premature beat has obvious clinical curative effect and less adverse reaction.It is worth using widely in clinic.